This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dillon, R. L.
Right arrow Articles by Muller, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dillon, R. L.
Right arrow Articles by Muller, W. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, December 2007, p. 8648-8657, Vol. 27, No. 24
0270-7306/07/$08.00+0     doi:10.1128/MCB.00866-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

An EGR2/CITED1 Transcription Factor Complex and the 14-3-3{sigma} Tumor Suppressor Are Involved in Regulating ErbB2 Expression in a Transgenic-Mouse Model of Human Breast Cancer{triangledown}

Rachelle L. Dillon,1,2 Stephen T. Brown,4 Chen Ling,1,2 Toshishiro Shioda,5 and William J. Muller1,2,3*

Molecular Oncology Group, McGill University Health Center,1 Departments of Biochemistry,2 Medicine, McGill University, Montreal, Quebec, Canada,3 Department of Biology, McMaster University, Hamilton, Ontario, Canada,4 Department of Tumor Biology, Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts5

Received 16 May 2007/ Returned for modification 19 July 2007/ Accepted 2 October 2007

Amplification and elevated expression of the ErbB2 receptor tyrosine kinase occurs in 20% of human breast cancers and is associated with a poor prognosis. We have previously demonstrated that mammary tissue-specific expression of activated ErbB2 under the control of its endogenous promoter results in mammary tumor formation. Tumor development was associated with amplification and overexpression of ErbB2 at both the transcript and protein levels. Here we demonstrate that the EGR2/Krox20 transcription factor and its coactivator CITED1 are coordinately upregulated during ErbB2 tumor induction. We have identified an EGR2 binding site in the erbB2 promoter and demonstrated by chromatin immunoprecipitation assays that EGR2 and CITED1 associate specifically with this region of the promoter. EGR2 and CITED1 were shown to associate, and expression from an erbB2 promoter-reporter construct was stimulated by EGR2 and was further enhanced by CITED1 coexpression. Furthermore, expression of the 14-3-3{sigma} tumor suppressor led to downregulation of ErbB2 protein levels and relocalization of EGR2 from the nucleus to the cytoplasm. Taken together, these observations suggest that, in addition to an increased gene copy number and upregulation of EGR2 and CITED1, an elevated erbB2 transcript level involves the loss of 14-3-3{sigma}, which sequesters a key transcriptional regulator of the erbB2 promoter.


* Corresponding author. Mailing address: Molecular Oncology Group, Royal Victoria Hospital, Room H5.63A, 687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada. Phone: (514) 934-1934, ext. 36384. Fax: (514) 843-1478. E-mail: william.muller{at}mcgill.ca

{triangledown} Published ahead of print on 15 October 2007.


Molecular and Cellular Biology, December 2007, p. 8648-8657, Vol. 27, No. 24
0270-7306/07/$08.00+0     doi:10.1128/MCB.00866-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Miller, J. K., Shattuck, D. L., Ingalla, E. Q., Yen, L., Borowsky, A. D., Young, L. J.T., Cardiff, R. D., Carraway, K. L. III, Sweeney, C. (2008). Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer. Cancer Res. 68: 8286-8294 [Abstract] [Full Text]